Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders
Movement Disorders, 04/25/2012
Joutsa J et al. – Increased monoaminergic activity in the medial orbitofrontal cortex might be associated with increased sensitivity for Impulse control disorders (ICDs) under dopamine–replacement therapy in Parkinson's Disease (PD).

![print MDLinx article: Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders print mdlinx article: Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders](/img/articles-print-off.png)
![email MDLinx article: Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders email mdlinx article: Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders](/img/articles-email-off.png)
![save MDLinx article to My Library: Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders save mdlinx article to my library: Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders](/img/articles-save-to-my-library-off.png)